GlaxoSmithKline Plc (GSK,GSK.L) Wednesday posted first-quarter pre-tax profit of 1.41 billion pounds, down from last year's 1.86 billion pounds. Profit attributable to the shareholders slid to 961 million pounds or 19.6 pence per share from 1.31 billion pounds or 26.0 pence per share a year ago.
Core profit attributable to shareholders for the quarter totaled 1.30 billion pounds, or 26.9 pence per share.
Quarterly turnover stood at 6.47 billion pounds, down from restated 6.64 billion pounds in the same period last year. However, excluding the impact of disposals, primarily the conclusion of the Vesicare co-promotion agreement in the US in the first quarter 2012 and the non-core OTC brands divested in the first half of 2012, turnover grew 2%.
In addition, the company still expects to deliver full-year earnings per share growth of 3-4% at constant exchange rates.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.